Search

King Baudouin Foundation – Calls with a relevance to hematology

Apr 06 2022 Posted in Stakeholder news and views

The King Baudouin Foundation is an actor for change and innovation, serving the public interest and increasing social cohesion. It endeavours to maximise its impact through capacity building among organisations and people who contribute to building a better society.

SGN-CD33A Combined with Hypomethylating Therapy Produces High Remission Rates among Older Patients with AML

Jun 11 2016 Posted in Press releases

Acute myeloid leukemia (AML) is an aggressive form of blood cancer in which the majority of cases express CD33 on the surface of the leukemia cells.

The root of evil: pre-leukemic clones that survive chemotherapy are linked to a higher risk of leukemia recurrence

Jun 10 2016 Posted in Press releases

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. Treatment with intensive chemotherapy often leads to a period of freedom from overt disease called a remission. However, recurrence of the disease is common.

VIRTUAL: EHA-TSH Hematology Tutorial

Jul 07 2021 Posted in Tutorial reports

June 25&26, 2021

Meeting Chairs:

Prof S Eichinger (European Hematology Association)
Prof H Özsan (Turkish Society of Hematology)
In close collaboration with the Turkish Society of Hematology, EHA has annually organized live, joint tutorials (nine in the series), which are organized as part of…

Position of EHA on Clinical Trials

Jul 01 2013 Posted in Advocacy news

The challenge
In Europe, the number of clinical trials is steadily decreasing. From 2007 to 2010, their number has decreased by some 20 percent from 5,028 to 4,193.

Congratulations to the 2021 Research Grant winners!

Jun 02 2021 Posted in Press releases

The Hague, 2 June 2021 –EHA congratulates nine talented researchers in hematology on their receipt of the EHA Research Grants 2021 after a rigorous selection process.